Literature DB >> 9342612

Retinal neovascularization in a case of macular branch retinal vein occlusion.

G Virgili1, S Caucci, P Lanzetta, C Salati, U Menchini.   

Abstract

BACKGROUND: Retinal neovascularization (RNV) has never been described in cases of macular branch retinal vein occlusion (MBRVO), due to the limited amount of ischemia in this form of retinal vein occlusion. Ischemic areas as wide as 5-10 disc diameters were required by previous studies to count as ischemic cases of central or major branch retinal vein occlusion. CASE REPORT: A 56-year-old woman who had been suffering from MBRVO for 3 years presented at the posterior pole a zone of non-perfusion, extending over 7.5 disc areas, and three small tufts of RNV. RNV regressed after two subsequent laser treatments of the ischemia. Retrohyaloid hemorrhage was observed 2 months after the first treatment.
CONCLUSION: Since the average diameter of the non-perfused area was about 2.75 disc diameters, this case demonstrates that small RNVs can appear in less extensive areas of ischemia than is generally believed.

Entities:  

Mesh:

Year:  1997        PMID: 9342612     DOI: 10.1007/bf00947091

Source DB:  PubMed          Journal:  Graefes Arch Clin Exp Ophthalmol        ISSN: 0721-832X            Impact factor:   3.117


  4 in total

1.  New vessel formation in retinal branch vein occlusion.

Authors:  J S Shilling; E M Kohner
Journal:  Br J Ophthalmol       Date:  1976-12       Impact factor: 4.638

2.  A randomized clinical trial of early panretinal photocoagulation for ischemic central vein occlusion. The Central Vein Occlusion Study Group N report.

Authors: 
Journal:  Ophthalmology       Date:  1995-10       Impact factor: 12.079

Review 3.  Ocular neovascularization with retinal vascular occlusion-III. Incidence of ocular neovascularization with retinal vein occlusion.

Authors:  S S Hayreh; P Rojas; P Podhajsky; P Montague; R F Woolson
Journal:  Ophthalmology       Date:  1983-05       Impact factor: 12.079

4.  Argon laser scatter photocoagulation for prevention of neovascularization and vitreous hemorrhage in branch vein occlusion. A randomized clinical trial. Branch Vein Occlusion Study Group.

Authors: 
Journal:  Arch Ophthalmol       Date:  1986-01
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.